ESOF 2010 EMCDDA ScC Session Marina Davoli, Roland Simon, Margareta Nilson

2 State of development Luigi Civalleri - ESOF Scientific Programme Coordinator Via Po 18, Torino (Italy) “ on behalf of ESOF2010 Programme Committee and organizing team, I congratulate all successful proponents. Welcome on board!” 218 proposals from 26 countries received/ 97 proposals were accepted Questions to be answered soon: 1. Speakers confirmed? Is the affiliation you provided correct? 2. Moderator chosen? 3. Date fixed? 4. Do you confirm that your session will be completely self-financed?

3 ESOF2010 Torino 3. – 7. July 110 ordinary sessions, 4 Plenary Sessions and 18 Keynote Talks 5 Nobel Prize winners. Speakers with scientific pre-eminence and communication skills, cultural and gender diversity Themes Sustainable living and moving Evolution, development and adaptation of organisms Moving into and up from our quantum world Responding to global needs Frontiers in energy research Science, knowledge and belief Memory and learning in organisms, social and artificial systems Languages, cultures and variability Integrating science with health care Policy – what follows?

4 Some facts on ESOF2008 Number of total participants: 4115 Number of accredited media: 511 Number of speakers: 452 Session’s attendance: - Plenary sessions: an average of Keynote and parallel sessions: an average of 104 Total number of Outreach participants:

5 The EMCDDA ScC Session: Synposis experiences and possibilities to improve implementation of findings describes how research has informed clinical practice and what problems this process can face. Clinical research on pharmacological and psychosocial treatment has changed the understanding and treatment of addictions, whereas behavioural treatment has partly developed through advances in qualitative research. Compared to first proposal: cut down by 50%, concentrated on treatment

6 The EMCDDA ScC Session: Structure Research informing clinical practice – what works, and what does not Where transfer works/worked for pharmacological treatment John Strang 10’ Where transfer works/worked for psychosocial/behavioural treatment Michael Farrell 10’ What limits and hinders transfer Jurgen Rehm 15’ Part II: Research informing practice – ways to narrow the gap From research synthesis to clinical guidelinesMarina Davoli 10’ Are guidelines of any use to clinicians?PierPaolo Pani 10’ Discussion with the panel: Ways to narrow the gap20’ Overall duration: 75 Minutes

7 Next steps Finalize list of speakers Agree on outline of presentations Guarantee funding and organise trips We will support Marina and Michael doing this